| Zuzana Hall, MD | |
|
1200 Mountain St Ste 230, Carson City, NV 89703-3867 | |
| (775) 882-1324 | |
| (775) 882-3859 |
| Full Name | Zuzana Hall |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 12 Years |
| Location | 1200 Mountain St Ste 230, Carson City, Nevada |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245761394 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 20626 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Healthy Living At Home -carson City, Llc | Carson city, NV | Home health agency |
| Carson Tahoe Regional Medical Center | Carson city, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carson Medical Group Professional Corporation | 4183520778 | 45 |
News Archive
MRC scientists have discovered a mechanism that prevents cells from transforming into cancer cells. As cells age they enter a state called senescence, a kind of suspended animation that allows a cell to keep functioning but prevents it from changing. This state can also be triggered by what's called an 'insult' to the cell, for example a signal from a cancer-initiating gene.
Medinol, a developer of Interventional Cardiology devices, announced today the completion of enrollment in its BIONICS trial, a global, prospective, randomized, multicenter, clinical trial designed to evaluate the safety and effectiveness of a new Coronary Stent System, the first ever elastomeric Drug Eluting Stent or eDES.
A paper authored by researchers from McLean Hospital has determined that esketamine, a nasal spray to treat severe depression, is currently too expensive for widespread use.
As the Journal of the American Medical Association (JAMA) reports on the actual decline in U.S. biomedical research funding, Autism Speaks, the nation's largest autism science and advocacy organization, again called on the federal government to immediately step up its efforts - and dramatically increase research funding - to address the growing national autism public health crisis.
Merck has thoroughly reviewed the safety data for sitagliptin, and sitagliptin was not associated with an increase in the incidence of pancreatitis in preclinical studies or in clinical trials of up to two years in duration with more than 6,000 patients.
› Verified 4 days ago
| Entity Name | Carson Medical Group Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780694620 PECOS PAC ID: 4183520778 Enrollment ID: O20031212000509 |
News Archive
MRC scientists have discovered a mechanism that prevents cells from transforming into cancer cells. As cells age they enter a state called senescence, a kind of suspended animation that allows a cell to keep functioning but prevents it from changing. This state can also be triggered by what's called an 'insult' to the cell, for example a signal from a cancer-initiating gene.
Medinol, a developer of Interventional Cardiology devices, announced today the completion of enrollment in its BIONICS trial, a global, prospective, randomized, multicenter, clinical trial designed to evaluate the safety and effectiveness of a new Coronary Stent System, the first ever elastomeric Drug Eluting Stent or eDES.
A paper authored by researchers from McLean Hospital has determined that esketamine, a nasal spray to treat severe depression, is currently too expensive for widespread use.
As the Journal of the American Medical Association (JAMA) reports on the actual decline in U.S. biomedical research funding, Autism Speaks, the nation's largest autism science and advocacy organization, again called on the federal government to immediately step up its efforts - and dramatically increase research funding - to address the growing national autism public health crisis.
Merck has thoroughly reviewed the safety data for sitagliptin, and sitagliptin was not associated with an increase in the incidence of pancreatitis in preclinical studies or in clinical trials of up to two years in duration with more than 6,000 patients.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Zuzana Hall, MD 1200 Mountain St Ste 230, Carson City, NV 89703-3867 Ph: (775) 882-1324 | Zuzana Hall, MD 1200 Mountain St Ste 230, Carson City, NV 89703-3867 Ph: (775) 882-1324 |
News Archive
MRC scientists have discovered a mechanism that prevents cells from transforming into cancer cells. As cells age they enter a state called senescence, a kind of suspended animation that allows a cell to keep functioning but prevents it from changing. This state can also be triggered by what's called an 'insult' to the cell, for example a signal from a cancer-initiating gene.
Medinol, a developer of Interventional Cardiology devices, announced today the completion of enrollment in its BIONICS trial, a global, prospective, randomized, multicenter, clinical trial designed to evaluate the safety and effectiveness of a new Coronary Stent System, the first ever elastomeric Drug Eluting Stent or eDES.
A paper authored by researchers from McLean Hospital has determined that esketamine, a nasal spray to treat severe depression, is currently too expensive for widespread use.
As the Journal of the American Medical Association (JAMA) reports on the actual decline in U.S. biomedical research funding, Autism Speaks, the nation's largest autism science and advocacy organization, again called on the federal government to immediately step up its efforts - and dramatically increase research funding - to address the growing national autism public health crisis.
Merck has thoroughly reviewed the safety data for sitagliptin, and sitagliptin was not associated with an increase in the incidence of pancreatitis in preclinical studies or in clinical trials of up to two years in duration with more than 6,000 patients.
› Verified 4 days ago
Carol L Alley, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3991 County Line Rd, Carson City, NV 89703 Phone: 775-378-8745 | |
Stephen Thomas Hewitt, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Medical Pkwy, Carson City, NV 89703 Phone: 775-445-8795 Fax: 775-445-5175 | |
Cynthia Novak, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1600 Medical Pkwy, Carson City, NV 89703 Phone: 775-445-8005 | |
Marirose Cutillar, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2527 N Carson St, Suite 190, Carson City, NV 89706 Phone: 775-887-5140 Fax: 775-884-3618 | |
Timothy Glenn Gentner, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Mountain St, Carson City, NV 89703 Phone: 775-882-1324 Fax: 775-882-3859 | |
Sally A Chimarusti, APN Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2874 N Carson St Ste 127, Carson City, NV 89706 Phone: 775-882-1300 Fax: 775-882-1300 | |
Lacey Eichhorst, MSN, APRN, FNP-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Mountain St Ste 230, Carson City, NV 89703 Phone: 775-882-1324 Fax: 775-882-3859 |